Webinar: Brazil Cosmetic Regulatory Compliance and Importation Requirements
GRP has teamed up with ChemLinked to bring you a webinar on Cosmetic Regulation and requirements in Brazil. The webinar will introduce the Brazilian cosmetic market, then specify the cosmetic regulatory framework, including cosmetics registration, labeling, and advertisement, and finally outline regulatory requirements for the importation of cosmetics into Brazil
Registration of Biologics in Brazil
Trying to register your biologic in Brazil? Read GRP’s blog to get a greater understand of the regulations, pathways and timelines.
How to make a Home-Made Face Mask: Health Authorities Recommendations
Learn how to make a home-made face mask based on health authority recommendations around the world.
Anvisa Clarifies on use of Chloroquine and Hydroxychloroquine as potential treatments of COVID-19
ANVISA clarifies that there are no conclusive studies proving the use of hydroxychloroquine and chloroquine as a treatment for COVID-19.
Anvisa Temporarily allows pharmacies to manufacturer and sell Hand-Sanitizer to the public
On March 18, Anvisa has authorized pharmacies to prepare and sell gel alcohol directly to the public. Anvisa intends to expand the access of these products to the population, considering the high number of pharmacies throughout Brazil
Brazil’s Anvisa Cancels Face-to-Face meeting due to Coronavirus
Anvisa announces they will be canceling Face-to Face meeting as preventative measures due to Coronovirus.
ANVISA NEW REGULATION FOR POST-APPROVAL CHANGES TO MEDICAL DEVICES: RDC 340/2020
On March 3, 2020, Anvisa published a new regulation “RDC 340/2020” that classifies the changes made to approved medical devices in Brazil, into three categories based on the level of risk .
Anvisa’s Call Notice 2/2020 : Similar Drug Notice
On Thursday (1/30), Anvisa published Call Notice 2/2020 , aimed at requesting information on similar drugs registered in Brazil.
BRAZIL APPROVES IMPORTATION OF MEDICAL CANNABIS
ANVISA new regulatory framework creates a new class of products subject to health surveillance: Cannabis- based products.
Brazil’s ANVISA successful implementation of the Medical Device Single Audit Program (MDSAP)
Brazil implements successful Medical Device Single Audit Program (MDSAP) and shows exciting results for the future of international inspection.
ANVISA -RDC 305/2019- Regulation for Custom-Made Medical Devices
On October 2019, Anvisa published its formal regulations for custom-made medical devices “RDC 305/2019. “
ANVISA Regulatory Priorities for Medical Devices in 2020
Anvisa announces its regulatory priorities for Medical Devices in 2020.